A cannabis business owner running for Congress signals a shift from outside advocacy to direct representation in federal policymaking. The move highlights the industry’s growing political maturity and push for practical reform.

As lawmakers debate tighter hemp restrictions, enforcement uncertainty is emerging as the biggest risk for operators. Federal and state conflict will shape how rules are applied, affecting competition, distribution, and compliance planning.

Trump’s push to reschedule cannabis signals growing federal recognition of medical use and opens pathways for expanded research and clearer CBD oversight. While not full legalization, the move reflects momentum rather than restriction.

A proposed federal cannabis legalization commission signals that lawmakers are seeking a real national framework. While it does not mean immediate legalization, it marks continued forward movement in federal cannabis policy.

The United States has officially moved cannabis to Schedule III, acknowledging accepted medical use and reducing long standing federal barriers. While cannabis remains federally illegal, the shift opens new pathways for research, healthcare integration, and industry stability.

Despite federal reclassification, cannabis businesses still face major barriers accessing traditional banking services. Large financial institutions remain cautious, forcing operators to rely on smaller lenders and alternative financing.

If cannabis moves to Schedule III, federal barriers around research, medical development, banking, and penalties could ease significantly. While cannabis would remain federally regulated, the change could unlock long awaited pathways for growth and stability.

Markets are reacting as President Trump is expected to address federal cannabis policy and possible reclassification to Schedule III. The move could ease banking, research, and tax barriers while keeping cannabis federally illegal.

Massachusetts has approved rules for licensed social cannabis consumption lounges, opening the door to cannabis cafes and experience driven venues. The move creates a new consumer channel that expands the industry beyond traditional retail while emphasizing safety and compliance.

Cannabis stocks jumped as investors reacted to renewed federal policy discussions around marijuana reclassification. A move away from Schedule I could ease tax and banking barriers, creating major structural changes for the industry.

A new federal law will ban most intoxicating hemp-derived THC products by imposing a 0.4 mg THC-per-container limit and prohibiting certain synthesized cannabinoids. The rule takes effect in November 2026 and could dramatically reshape the hemp-based wellness market.

Virginia’s Joint Commission has proposed a sweeping adult-use cannabis framework ahead of the state’s expected 2026 retail launch. The plan removes local opt-outs, elevates micro-businesses, and establishes clear rules for licensing, zoning, testing, and delivery.

Rumors are growing in Washington that a second Trump administration may aggressively pursue federal cannabis rescheduling. If it happens, it would reshape banking, insurance, taxes, and interstate commerce — transforming the entire cannabis industry.

Rep. Dina Titus is demanding answers from the U.S. Attorney General after a DOJ memo signaled renewed enforcement on cannabis offenses. Her letter raises major concerns for state-legal operators who need clear federal guidance to protect their businesses and plan for the future.

Rep. Nancy Mace has introduced draft legislation aimed at reversing the new federal ban on intoxicating hemp products. The proposal could offer major relief to the $28 billion hemp-THC sector, which was blindsided by the ban buried in the government-funding deal.

Texas avoided a state-level THC ban, but a new federal spending bill could outlaw most hemp-derived THC products nationwide. Industry leaders warn the move could devastate the multi-billion-dollar hemp sector and force thousands of operators to pivot or shut down.

Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.

A federal spending bill to reopen the government includes provisions to ban many hemp-derived THC products, such as Delta-8 and hemp-based gummies and beverages. The move could devastate parts of the hemp industry and signals increasing federal intervention in cannabis regulation.

Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.

Republican support for federal cannabis legalization has dropped from 55% to 40%, according to a new Gallup poll. The decline highlights growing political polarization around cannabis — and potential challenges for federal reform heading into 2026.